Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #794 on NRX Pharmaceuticals Inc (NRXP)
Joe Kaplan
03/01/22 3:42 PM
#795 RE: Good Stick #794
georgejjl
03/01/22 8:20 PM
#797 RE: Good Stick #794
Earlier treatment leads to improved outcomes. Aviptadil showed a manageable safety profile, with no unexpected serious adverse events.